Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 6—June 2019
Research

Sequential Emergence and Wide Spread of Neutralization Escape Middle East Respiratory Syndrome Coronavirus Mutants, South Korea, 2015

Yeon-Sook Kim1, Abdimadiyeva Aigerim1, Uni Park1, Yuri Kim, Ji-Young Rhee, Jae-Phil Choi, Wan Beom Park, Sang Won Park, Yeonjae Kim, Dong-Gyun Lim, Kyung-Soo Inn, Eung-Soo Hwang, Myung-Sik Choi, and Nam-Hyuk Cho2Comments to Author 
Author affiliations: Chungnam National University School of Medicine, Daejeon, South Korea (Y.-S. Kim); Seoul National University College of Medicine, Seoul, South Korea (A. Aigerim, U. Park, Y. Kim, W.B. Park, S.W. Park, E.-S. Hwang, M.-S. Choi, N.-H. Cho); Dankook University College of Medicine, Cheonan, South Korea (J.-Y. Rhee); Seoul Medical Center, Seoul (J.-P. Choi); National Medical Center, Seoul (Y. Kim, D.-G. Lim, H.S. Shin); Kyung Hee University, Seoul (K.-S. Inn); Seoul National University Medical Research Center and Bundang Hospital, Seoul (N.H. Cho)

Main Article

Figure 1

Emergence and spread of Middle East respiratory syndrome coronavirus (MERS-CoV) bearing the I529T or D510G mutation in the spike protein during the 2015 outbreak in South Korea. Transmission chain of infection and the timeline of potential virus exposure, symptom onset, date of specimen collection from patients, and identified mutation in the spike protein of MERS-CoV analyzed in this study. Case-patients’ IDs are colored on the basis of disease severity (gray, group I; black, group II; pink: gr

Figure 1. Emergence and spread of Middle East respiratory syndrome coronavirus (MERS-CoV) bearing the I529T or D510G mutation in the spike protein during the 2015 outbreak in South Korea. Transmission chain of infection and the timeline of potential virus exposure, symptom onset, date of specimen collection from patients, and identified mutation in the spike protein of MERS-CoV analyzed in this study. Case-patients’ IDs are colored on the basis of disease severity (gray, group I; black, group II; pink: group III; red, group IV). Spike sequences analyzed by targeted deep sequencing (10) are denoted as a square with black (single genotype) or red (mixed genotypes with wild-type) borderline. Others are marked as circles (direct sequencing). Detailed information on patients’ characteristics and their associated spike sequences of MERS-CoV are available in Appendix Table 1 and 2). WT, wild-type.

Main Article

References
  1. Hui  DS, Azhar  EI, Kim  YJ, Memish  ZA, Oh  MD, Zumla  A. Middle East respiratory syndrome coronavirus: risk factors and determinants of primary, household, and nosocomial transmission. Lancet Infect Dis. 2018;18:e217–27. DOIPubMedGoogle Scholar
  2. Korea Centers for Disease Control and Prevention. Middle East respiratory syndrome coronavirus outbreak in the Republic of Korea, 2015. Osong Public Health Res Perspect. 2015;6:269–78. DOIPubMedGoogle Scholar
  3. Assiri  A, McGeer  A, Perl  TM, Price  CS, Al Rabeeah  AA, Cummings  DA, et al.; KSA MERS-CoV Investigation Team. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 2013;369:407–16. DOIPubMedGoogle Scholar
  4. Amer  H, Alqahtani  AS, Alzoman  H, Aljerian  N, Memish  ZA. Unusual presentation of Middle East respiratory syndrome coronavirus leading to a large outbreak in Riyadh during 2017. Am J Infect Control. 2018;46:1022–5. DOIPubMedGoogle Scholar
  5. Parrish  CR, Holmes  EC, Morens  DM, Park  EC, Burke  DS, Calisher  CH, et al. Cross-species virus transmission and the emergence of new epidemic diseases. Microbiol Mol Biol Rev. 2008;72:457–70. DOIPubMedGoogle Scholar
  6. Kim  Y, Cheon  S, Min  CK, Sohn  KM, Kang  YJ, Cha  YJ, et al. Spread of mutant Middle East respiratory syndrome coronavirus with reduced affinity to human CD26 during the South Korean outbreak. MBio. 2016;7:e00019. DOIPubMedGoogle Scholar
  7. Rockx  B, Donaldson  E, Frieman  M, Sheahan  T, Corti  D, Lanzavecchia  A, et al. Escape from human monoclonal antibody neutralization affects in vitro and in vivo fitness of severe acute respiratory syndrome coronavirus. J Infect Dis. 2010;201:946–55. DOIPubMedGoogle Scholar
  8. Li  W, Wong  SK, Li  F, Kuhn  JH, Huang  IC, Choe  H, et al. Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions. J Virol. 2006;80:4211–9. DOIPubMedGoogle Scholar
  9. Tang  XC, Agnihothram  SS, Jiao  Y, Stanhope  J, Graham  RL, Peterson  EC, et al. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution. Proc Natl Acad Sci U S A. 2014;111:E2018–26. DOIPubMedGoogle Scholar
  10. Kleine-Weber  H, Elzayat  MT, Wang  L, Graham  BS, Müller  MA, Drosten  C, et al. Mutations in the spike protein of Middle East respiratory syndrome coronavirus transmitted in Korea increase resistance to antibody-mediated neutralization. J Virol. 2019;93:E01381–18.PubMedGoogle Scholar
  11. Park  D, Huh  HJ, Kim  YJ, Son  DS, Jeon  HJ, Im  EH, et al. Analysis of intrapatient heterogeneity uncovers the microevolution of Middle East respiratory syndrome coronavirus. Cold Spring Harb Mol Case Stud. 2016;2:a001214.
  12. Min  CK, Cheon  S, Ha  NY, Sohn  KM, Kim  Y, Aigerim  A, et al. Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity. Sci Rep. 2016;6:25359. DOIPubMedGoogle Scholar
  13. Wong  G, Liu  W, Liu  Y, Zhou  B, Bi  Y, Gao  GF. MERS, SARS, and Ebola: the role of super-spreaders in infectious disease. Cell Host Microbe. 2015;18:398–401. DOIPubMedGoogle Scholar
  14. Raj  VS, Mou  H, Smits  SL, Dekkers  DHW, Müller  MA, Dijkman  R, et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature. 2013;495:251–4. DOIPubMedGoogle Scholar
  15. Cockrell  AS, Peck  KM, Yount  BL, Agnihothram  SS, Scobey  T, Curnes  NR, et al. Mouse dipeptidyl peptidase 4 is not a functional receptor for Middle East respiratory syndrome coronavirus infection. J Virol. 2014;88:5195–9. DOIPubMedGoogle Scholar
  16. Wu  K, Peng  G, Wilken  M, Geraghty  RJ, Li  F. Mechanisms of host receptor adaptation by severe acute respiratory syndrome coronavirus. J Biol Chem. 2012;287:8904–11. DOIPubMedGoogle Scholar
  17. Kan  B, Wang  M, Jing  H, Xu  H, Jiang  X, Yan  M, et al. Molecular evolution analysis and geographic investigation of severe acute respiratory syndrome coronavirus-like virus in palm civets at an animal market and on farms. J Virol. 2005;79:11892–900. DOIPubMedGoogle Scholar
  18. Li  W, Zhang  C, Sui  J, Kuhn  JH, Moore  MJ, Luo  S, et al. Receptor and viral determinants of SARS-coronavirus adaptation to human ACE2. EMBO J. 2005;24:1634–43. DOIPubMedGoogle Scholar
  19. Lu  G, Wang  Q, Gao  GF. Bat-to-human: spike features determining ‘host jump’ of coronaviruses SARS-CoV, MERS-CoV, and beyond. Trends Microbiol. 2015;23:468–78. DOIPubMedGoogle Scholar
  20. Yuan  Y, Cao  D, Zhang  Y, Ma  J, Qi  J, Wang  Q, et al. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat Commun. 2017;8:15092. DOIPubMedGoogle Scholar
  21. Doud  MB, Lee  JM, Bloom  JD. How single mutations affect viral escape from broad and narrow antibodies to H1 influenza hemagglutinin. Nat Commun. 2018;9:1386. DOIPubMedGoogle Scholar
  22. Oh  MD, Park  WB, Choe  PG, Choi  SJ, Kim  JI, Chae  J, et al. Viral load kinetics of MERS coronavirus infection. N Engl J Med. 2016;375:1303–5. DOIPubMedGoogle Scholar
  23. Yang  JS, Park  S, Kim  YJ, Kang  HJ, Kim  H, Han  YW, et al. Middle East respiratory syndrome in 3 persons, South Korea, 2015. Emerg Infect Dis. 2015;21:2084–7. DOIPubMedGoogle Scholar
  24. Lee  JY, Kim  YJ, Chung  EH, Kim  DW, Jeong  I, Kim  Y, et al. The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015. BMC Infect Dis. 2017;17:498. DOIPubMedGoogle Scholar

Main Article

1These first authors contributed equally to this article.

2These authors were co-principal investigators.

Page created: May 20, 2019
Page updated: May 20, 2019
Page reviewed: May 20, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external